Evaluation of Uterine Artery Embolisation on Size and Symptomatology of Leiomyoma Under Patient Controlled Analgesia with Meperidine
Keywords:Interventional radiology, Uterine leiomyoma, embolization, pain relief.
Aim: We aimed to present our experience on uterine artery embolization (UAE) under intravenous (iv) patient controlled analgesia (PCA) with meperidine. Methods: Twelve patients, aged between 30 to 45 years with solitary leiomyoma having pelvic pain or heavy menstruel bleeding were included. The size and location of uterine leiomyomas were determined by transvaginal ultrasound. The UAE was performed after angiography of the uterine artery blood supply by percutaneous unilateral common femoral arterial access under iv PCA with meperidine. Both uterine arteries were catheterized with co-axial microcatheter system through this route and embolized between 300 to 900 Î¼m microspheres under fluoroscopic guidance. Results: The fibriod volumes measured after 3 and 6 months significantly decreased when compared to the pre-embolization volumes. Symptoms of irregular excessive menstruel bleeding, pelvic discomfort, bowel and bladder dysfunction, pressure sensation in the lower abdomen and pain during intercourse markedly regressed. Pain relief was provided by iv PCA from the onset of the procedure until 24 hours after the procedure. Conclusion: The UAE procedure under iv PCA with meperidine has been shown to be a comfortable technique that might be offered to patients with symptomatic fibroids in non-reproductive age or desire for not having a child.
Wallach EE, Vlahos NF. Uterine myomas: An overview of development, clinical features, and management. Obstet Gynecol 2004; 104:393–406. http://dx.doi.org/10.1097/01.AOG.0000136079.62513.39
Duhan N, Sirohiwal D. Uterine myomas revisited. Eur J Obstet Gynecol Reprod Biol 2010; 152: 119–125. http://dx.doi.org/10.1016/j.ejogrb.2010.05.010
Marsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am 2006; 33: 59–67. http://dx.doi.org/10.1016/j.ogc.2005.12.001
Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol 2008; 198; 168.e1– 168.e9.
Valladares F, Frias I, Baez D, Garcia C, Lopez FJ, Fraser JD, et al. Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril 2006; 86: 1736–43. http://dx.doi.org/10.1016/j.fertnstert.2006.05.047
Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids.Conchrane Database Syst Rev 2012; 16; 5: CD005073.
Garry R, Fountain J, Mason S, Hawe J, Napp V, Abbott J, et al. The Evaluate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004; 328 (7432): 129. http://dx.doi.org/10.1136/bmj.37984.623889.F6
Greenwood LH, Glickman MG, Schwartz PE, Morse SS, Denny DF. Obstetric and non malignant gynecologic bleeding: treatment with angiographic embolization. Radiology 1987; 164: 155–9.
Goodwin SC, Vedantham S, McLucas B, Forno AE, PeRrella R. Preliminary experience with uterine artery embolization for uterine fibroids. J Vasc Interv Radiol 1997; 8: 517-26. http://dx.doi.org/10.1016/S1051-0443(97)70603-1
Ravina JH, Bouret JM, Ciraru-Vigneron N, Repiquet D, Herbreteau D, Aymard A, et al. Recourse to particular arterial embolization in the treatment of some uterine leiomyoma. Bull Acad Nat Med 1997; 18:233–43.
Van der Kooij SM, Moolenaar LM, Ankum WM, Rekeers JA, Mol BWJ, Hehenkamp WJK. Epidural analgesia versus patient controlled analgesia for pain relief im uterine artery embolization for uterine fibroids: A decision analysis. Cardiovasc Intervent Radiol 2013; 36: 1514-20. http://dx.doi.org/10.1007/s00270-013-0607-1
Kim SY, Chang CH, Lee JS, Kim MD, Han DW. Comparison of the efficacy of dexmedetomidine plus fentanyl patient controlled analgesia with fentanyl patient controlled analgesia for pain control in uterine artery embolization for symptomatic fibroid tumours or adenomyosis: A prospective, randomized study. J Vasc Intervent Radiol 2013; 24: 779-86. http://dx.doi.org/10.1016/j.jvir.2013.02.034
Worthington-Kirsch RL, Andrews RT, Siskin GP, ShlanskyGoldberg R, Lipman JC, Goodwin SC, Bonn J, Hovsepian DM. II. Uterine fibroid embolization: technical aspects. Tech Vasc Interv Radiol 2002; 5: 17-34. http://dx.doi.org/10.1053/tvir.2002.124101
Pelage JP, Cazejust J, Pluot E, Le Dref O, et al. Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization. Radiographics 2005; 25: S99-S117. http://dx.doi.org/10.1148/rg.25si055510
Mukhopadhaya N, De Silva C, Manyonda IT. Conventional myomectomy. Best Pract Res Clin Obstet Gynaecol 2008; 22:677-705. http://dx.doi.org/10.1016/j.bpobgyn.2008.01.012
van der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and meta-analysis. Am J Obstet Gynecol 2011; 205: 317.e18.
Tropeano G, Di Stasi C, Amoroso S, Vizzielli G, Mascilini F, Scambia G. Incidence and risk factors for clinical failure of uterine leiomyoma embolization. Obstet Gynecol 2012; 120: 269-276. http://dx.doi.org/10.1097/AOG.0b013e31825cb88e
Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 1999; 10: 1293–303. http://dx.doi.org/10.1016/S1051-0443(99)70235-6